FOXO3 (forkhead box O3) is a transcription factor that plays a key role in blood sugar regulation. Under low insulin conditions (e.g., fasting), FOXO3 translocates to the nucleus and promotes gluconeogenesis in the liver by activating genes such as G6PC and PCK1. It also regulates antioxidant enzymes (e.g., SOD2, catalase) and cell cycle inhibitors, linking it to stress resistance and longevity. Impaired FOXO3 signaling contributes to insulin resistance and hyperglycemia. Genetic variants in FOXO3 (e.g., rs2802292) have been associated with human longevity and better metabolic health in GWAS, but the effect size on fasting glucose is modest. Lifestyle factors (diet, exercise) dominate glycemic control. No consumer DNA test for FOXO3 is clinically validated for diabetes risk prediction. Evidence: human-strong (animal models, human observational, GWAS). Caveat: single-gene effects are small; a standard fasting glucose or HbA1c test is more actionable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-6b09618d87a6151b9d91fa41